Noticeably, after Bonferroni correction for multiple testing, only the association of MMP-9 -1562C/T polymorphism (additive and dominant models) in the subgroup of smoker-based controls and COPD risk persisted significantly, while no other associations were found. This evidence concerns the gene MMP9 and chronic obstructive pulmonary disease.